1. Home
  2. AQST vs UTL Comparison

AQST vs UTL Comparison

Compare AQST & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • UTL
  • Stock Information
  • Founded
  • AQST 2004
  • UTL 1984
  • Country
  • AQST United States
  • UTL United States
  • Employees
  • AQST N/A
  • UTL N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • UTL Power Generation
  • Sector
  • AQST Health Care
  • UTL Utilities
  • Exchange
  • AQST Nasdaq
  • UTL Nasdaq
  • Market Cap
  • AQST 809.3M
  • UTL 889.7M
  • IPO Year
  • AQST 2018
  • UTL N/A
  • Fundamental
  • Price
  • AQST $5.59
  • UTL $47.69
  • Analyst Decision
  • AQST Strong Buy
  • UTL Hold
  • Analyst Count
  • AQST 7
  • UTL 1
  • Target Price
  • AQST $10.00
  • UTL $55.00
  • AVG Volume (30 Days)
  • AQST 3.0M
  • UTL 92.0K
  • Earning Date
  • AQST 11-05-2025
  • UTL 11-03-2025
  • Dividend Yield
  • AQST N/A
  • UTL 3.78%
  • EPS Growth
  • AQST N/A
  • UTL N/A
  • EPS
  • AQST N/A
  • UTL 2.85
  • Revenue
  • AQST $43,397,000.00
  • UTL $502,000,000.00
  • Revenue This Year
  • AQST N/A
  • UTL $6.14
  • Revenue Next Year
  • AQST $51.39
  • UTL $9.04
  • P/E Ratio
  • AQST N/A
  • UTL $16.70
  • Revenue Growth
  • AQST N/A
  • UTL 1.03
  • 52 Week Low
  • AQST $2.12
  • UTL $44.61
  • 52 Week High
  • AQST $7.55
  • UTL $61.42
  • Technical
  • Relative Strength Index (RSI)
  • AQST 37.83
  • UTL 45.94
  • Support Level
  • AQST $5.44
  • UTL $46.96
  • Resistance Level
  • AQST $6.85
  • UTL $48.75
  • Average True Range (ATR)
  • AQST 0.42
  • UTL 1.28
  • MACD
  • AQST -0.20
  • UTL -0.25
  • Stochastic Oscillator
  • AQST 7.47
  • UTL 26.90

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About UTL UNITIL Corporation

Unitil Corp is a holding company, through its subsidiaries it is engaged in the local distribution of electricity and natural gas throughout its service territories in the states of New Hampshire, Massachusetts, and Maine. The Company has two operating and reportable segments: Utility Electric Operations and Utility Gas Operations. Majority of revenue is gained from Electric Segment.

Share on Social Networks: